Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylsalicylic acid to reduce mortality in ICU patients
2012-002235-29Phase 3Terminated
- Sponsor
- Medical University of Vienna
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in critical illness comparing Aspirin i.v with Placebo (2 arms). Primary endpoints: 28-day mortality and 90-day mortality. Started Oct 2012; status: terminated.
02
Drugs
aspirin
03
Conditions
critical illness
Beyond the preview
Go deeper on 2012-002235-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002235-29.